Philipp Hainzl has been heading the Viennese life sciences platform LISAvienna since September 2020. He is also responsible for the Vienna Business Agency's Startup Labs at the Vienna BioCenter and committed to providing additional laboratory space as well as expanding the life sciences infrastructure for innovative companies in Vienna.

His career path so far has taken him from academic research at the Center for Cancer Research at the Medical University of Vienna to the biotech start-ups Haplogen and Horizon Discovery, and the “big pharma” company Takeda. In addition to his degree in genetic engineering and biotechnology from the University of Vienna, he brings valuable experience in biotech and pharmaceutical management, lean management and customer support to LISAvienna.